Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Seizures: Classification01:13

Seizures: Classification

1.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification.

Nature communications·2026
Same author

Gut-Brain Axis Modulation by Short-Chain Fatty Acids Exerts Disease-Modifying Effects in a Murine Model of Drug-Resistant Epilepsy.

Annals of neurology·2026
Same author

On-site exposure to clinical epilepsy practice for experimental scientists engaged in epilepsy research: A pilot study by the ILAE commission on neurobiology.

Epilepsia open·2026
Same author

VAPB confers selective neuroprotection by driving autophagic degradation of pathogenic aggregates in ALS.

Acta neuropathologica communications·2026
Same author

The phosphoproteomic landscape of the neurological manifestations in tuberous sclerosis complex.

Acta neuropathologica·2026
Same author

Associations of cognitive and behavioural impairment in ALS with brain pathology: pTDP-43 versus microglial activation.

Journal of neurology·2026

Related Experiment Video

Updated: Jan 8, 2026

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus
05:33

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus

Published on: June 23, 2022

3.2K

Inflammation in epilepsy: clinical observations.

Eleonora Aronica1, Peter B Crino

  • 1Department of Neuro Pathology, University of Amsterdam and Epilepsy Institute, the Netherlands. e.aronica@amc.uva.nl

Epilepsia
|May 6, 2011
PubMed
Summary

Neuroinflammation is increasingly linked to focal epilepsy, potentially causing seizures and cognitive issues. Research explores inflammatory biomarkers and neuroimaging for targeted anti-inflammatory treatments in epilepsy patients.

More Related Videos

Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.9K
Investigating the Function of Deep Cortical and Subcortical Structures Using Stereotactic Electroencephalography: Lessons from the Anterior Cingulate Cortex
09:00

Investigating the Function of Deep Cortical and Subcortical Structures Using Stereotactic Electroencephalography: Lessons from the Anterior Cingulate Cortex

Published on: April 15, 2015

12.8K

Related Experiment Videos

Last Updated: Jan 8, 2026

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus
05:33

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus

Published on: June 23, 2022

3.2K
Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.9K
Investigating the Function of Deep Cortical and Subcortical Structures Using Stereotactic Electroencephalography: Lessons from the Anterior Cingulate Cortex
09:00

Investigating the Function of Deep Cortical and Subcortical Structures Using Stereotactic Electroencephalography: Lessons from the Anterior Cingulate Cortex

Published on: April 15, 2015

12.8K

Area of Science:

  • Neurology
  • Immunology
  • Neuroscience

Background:

  • Emerging evidence links inflammatory processes to various focal epilepsies.
  • Neuroinflammation may contribute to seizure development, perpetuation, and associated mood/cognitive dysfunction.

Purpose of the Study:

  • To review recent findings on inflammatory response in human focal epilepsy.
  • To evaluate biomarkers and neuroimaging for studying neuroinflammation in epilepsy.
  • To identify patient groups potentially benefiting from anti-inflammatory therapies.

Main Methods:

  • Review of recent scientific literature on neuroinflammation and epilepsy.
  • Evaluation of cerebrospinal fluid (CSF) and serum biomarkers.
  • Assessment of in vivo neuroimaging techniques for chronic epilepsy patients.

Main Results:

  • Growing observations support the role of inflammation in human focal epilepsy.
  • Biomarkers in CSF and serum show potential for identifying epilepsy-associated inflammation.
  • Neuroimaging offers in vivo insights into inflammatory reactions in chronic epilepsy.

Conclusions:

  • Inflammation is a significant factor in focal epilepsy.
  • Biomarker and neuroimaging approaches are promising for diagnosis and treatment selection.
  • Targeted anti-inflammatory or immunomodulatory therapies could benefit specific epilepsy patient populations.